Currently, out of the existing stock ratings of Cecilia Furlong - 154 which are a Hold (53.29%), 123 which are a Buy (42.56%), 12 which are a Sell (4.15%)

Cecilia Furlong

Work Performance Price Targets & Ratings Chart

Analyst Cecilia Furlong works at MORGAN STANLEY and is covering the Healthcare sector with 575 price targets and ratings displayed on 28 stocks. Previously, Cecilia Furlong worked at CANACCORD.

Cecilia Furlong's average stock forecast success ratio is 56.79% with an average time for price targets to be met of 122.18 days.

Most recent stock forecast was given on SGHT, at 13-Sep-2023.

Wall Street Analyst Cecilia Furlong

Analyst best performing recommendations are on VAPO (VAPOTHERM).
The best stock recommendation documented was for IRTC (IRHYTHM TECHNOLOGIES) at 1/7/2022. The price target of $129 was fulfilled within 3 days with a profit of $27.05 (26.53%) receiving and performance score of 88.44.

Average potential price target upside

of $47.14 (14.69%) on ABMD (ABIOMED).
of $37.01 (15.46%) on SYK (STRYKER).
of $28.88 (11.59%) on PODD (INSULET).

ABT Abbott Laboratories ALC Alcon CRY CryoLife EW Edwards Lifesciences SGHT SWAV ShockWave Medical TMDX TransMedics Group VAPO Vapotherm BSX Boston Scientific LUNG Pulmonx BAX Baxter International DXCM DexCom IRTC iRhythm Technologies ISRG Intuitive Surgical NVRO Nevro AORT BLCO EMBC TFX Teleflex VRAY ViewRay MDT Medtronic plc NARI Inari Medical SYK Stryker ZBH Zimmer Biomet Holdings ABMD Abiomed ATRC AtriCure AXNX Axonics Modulation Technologies PODD Insulet

Show more stocks

Analyst name

Rating

Current price target

Potential distance

Previous price target

Date

Price targets met ratio

Average potential upside

Average time for PT to be met

Performance score

Matt Miksic (CREDIT SUISSE)